The Challenge of Change - Managing Excipients Control
Colorcon
05-Dec-2011 - The US FDA has published draft guidance to help companies submit marketing applications for API-excipient co-crystals.
01-Dec-2011 - India-based Vivimed Labs is buying Uquifa for £35m ($55m) to add API capabilities in Europe and Latin America.
30-Nov-2011 - Aurobindo Pharma says a fire that broke out at its manufacturing plant in India injuring three employees did not disrupt production operations.
30-Nov-2011 - Ideal Cures says its new Instacoat E Series film can cut tablet coating times in half and save manufacturers money.
30-Nov-2011 - Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and help manufacturers save money.
29-Nov-2011 - High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.
29-Nov-2011 - USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.
28-Nov-2011 - in-PharmaTechnologist presents its round-up of the latest drug delivery research developments in the pharmaceutical world, including tumour targeting peptides and lipid nanoparticle drug-delivery technology.
24-Nov-2011 - Biocon is close to signing an agreement with a partner willing to inject cash into its experimental insulin pill, said its MD.
23-Nov-2011 - pSivida has inked a technology evaluation agreement with an unnamed global pharma over its Durasert drug delivery technology.
23-Nov-2011 - GlaxoSmithKline (GSK) has urged the US FDA consider the absorption of nanomaterials in the gastrointestinal (GI) tract within its proposal for new regulations on nanotechnology.
23-Nov-2011 - Shire has submitted EMA and FDA regulatory filings to add ‘substantial manufacturing capacity’ for Vpriv (velaglucerase alfa).
22-Nov-2011 - FDA draft guidance defines nanoparticles too broadly and could result in APIs being categorised as nanomaterials, industry said.
22-Nov-2011 - Novavax is leasing a cGMP plant in Maryland under ‘very favourable terms’ to meet anticipated demand for its VLP vaccines.
21-Nov-2011 - Gold nanoparticles can target endothelial cells to cut the supply of oxygen to most types of tumour, according to a new study.
17-Nov-2011 - Ashland expects integration of ISP and demand for pharma ingredients to drive “accelerated growth” in the next few years.
17-Nov-2011 - Net profit at Indian API and formulation business Aanjaneya Lifecare jumped as it enacted post-IPO expansion plans to ‘dominate’ its markets.
17-Nov-2011 - India plans to end price control of bulk drugs as the practice ‘is inherently anti-competitive’ and gives China an advantage.
16-Nov-2011 - IPEC India membership dues will be fair for excipient manufacturers, users and distributors in the country according to the IPEC Federation.
16-Nov-2011 - Boehringer Ingelheim is investing $65m (€48m) in a US API manufacturing facility to meet its early development needs.
16-Nov-2011 - Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments.
15-Nov-2011 - Merck & Co has gained access to spray-dried dispersion technology through an agreement with Bend Research.
15-Nov-2011 - To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.
14-Nov-2011 - Bristol-Myers Squibb has penned a technology transfer agreement with the Brazilian government in what it says is a bid to increase access to HIV drug Reyataz (atazanavir sulfate) in the area.
14-Nov-2011 - Indian excipient manufacturers could have a new trade body in early 2012 according to an international industry organisation asked to set up an association in the country.